Tower Research Capital LLC (Trc) Precision Biosciences Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.34 - $0.69 $7,958 - $16,150	23,406 Added 413.61%	29,065 $9,000
Q2 2023 Aug 14, 2023	BUY	$0.52 - $0.91 $2,890 - $5,058	5,559 Added 5559.0%	5,659 $2,000
Q1 2023 May 09, 2023	SELL	$0.7 - $1.41 $7,382 - $14,871	-10,547 Reduced 99.06%	100 $0
Q4 2022 Feb 10, 2023	SELL	$0.97 - $45.0 $14,550 - $675,000	-15,000 Reduced 58.49%	10,647 $13,000
Q3 2022 Nov 10, 2022	BUY	$1.22 - $40.8 $21,966 - $734,604	18,005 Added 235.61%	25,647 $34,000
Q2 2022 Aug 15, 2022	BUY	$1.15 - $3.34 $5,066 - $14,716	4,406 Added 136.16%	7,642 $12,000
Q1 2022 May 12, 2022	SELL	$2.96 - $7.76 $14,551 - $38,148	-4,916 Reduced 60.3%	3,236 $10,000
Q4 2021 Feb 14, 2022	BUY	$7.4 - $11.66 $20,660 - $32,554	2,792 Added 52.09%	8,152 $61,000
Q3 2021 Nov 15, 2021	BUY	$9.18 - $14.15 $20,150 - $31,059	2,195 Added 69.35%	5,360 $62,000
Q2 2021 Aug 16, 2021	SELL	$8.07 - $12.52 $21,450 - $33,278	-2,658 Reduced 45.65%	3,165 $40,000
Q1 2021 May 17, 2021	SELL	$8.57 - $15.79 $135,971 - $250,524	-15,866 Reduced 73.15%	5,823 $60,000
Q4 2020 Feb 16, 2021	SELL	$5.98 - $12.47 $127,804 - $266,508	-21,372 Reduced 49.63%	21,689 $181,000
Q3 2020 Nov 16, 2020	BUY	$4.65 - $8.73 $162,257 - $304,624	34,894 Added 427.26%	43,061 $265,000
Q2 2020 Aug 13, 2020	BUY	$4.66 - $8.7 $33,165 - $61,917	7,117 Added 677.81%	8,167 $68,000
Q1 2020 May 15, 2020	BUY	$5.05 - $15.01 $5,302 - $15,760	1,050 New	1,050 $6,000
Q4 2019 Feb 07, 2020	SELL	$6.32 - $19.66 $7,767 - $24,162	-1,229 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$8.03 - $14.82 $3,733 - $6,891	-465 Reduced 27.45%	1,229 $10,000
Q2 2019 Aug 13, 2019	BUY	$11.88 - $16.94 $20,124 - $28,696	1,694 New	1,694 $22,000

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $584M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account